BACKGROUND: Enabling strategies (ESs) are increasingly used during percutaneous coronary intervention for chronic total occlusive disease (CTO-PCI), enhancing procedural success. Using the British Cardiovascular Society dataset, we examined changes in the use of ESs and procedural/ clinical outcomes for CTO-PCI.
P
ercutaneous coronary intervention for chronic total occlusive disease (CTO-PCI) has evolved rapidly in recent years. As well as rapid advances in the steps forward in the technologies available to facilitate these procedures, operator understanding, skills, and techniques have also progressed with many international registries now reporting success rates for CTO-PCI of over 80%. [1] [2] [3] These CTO registries demonstrate superiority of a hybrid approach, using enabling strategies (ESs), including antegrade or retrograde wire escalation, and dissection reentry techniques. [4] [5] [6] [7] However, a recent study of 1301 procedures performed at 11 US CTO centers between 2012 and 2015 demonstrated a higher rate of major adverse cardiovascular events associated with a retrograde approach compared with an antegrade approach (4.3% versus 1.1%; P<0.001). 8 Therefore, these and other data suggest that the high procedural success rates now achievable with complex CTO-PCI strategies might come at a clinical cost. Additionally, there are also limited published data on a national level on CTO-PCI procedures with respect to success rates and outcomes, where data are not restricted to CTO specialist centers. In a previous National Cardiovascular Data Registry study, it was demonstrated that CTO-PCI was infrequently undertaken and was associated with lower procedural success and higher complication rates compared with non-CTO-PCI. 9 Therefore, there is uncertainty as to whether the safety and efficacy of advanced CTO strategies demonstrated from CTO specialists working in CTO centers can be reproduced on a wider national basis.
In a recent study of coronary perforation using data derived from the British Cardiovascular Intervention Society (BCIS) dataset, we identified a relationship between the number of CTO ESs used and coronary perforation. 10, 11 The current analysis examines CTO-PCI practice on a national basis and reports the association between the number of ESs used and procedural success, the acute procedural complications associated with ES use, and the clinical outcomes of patients categorized by the number of ESs used.
METHODS
The data, analytic methods, and study materials will be available to other researchers upon request for purposes of reproducing the results or replicating the procedure.
Study Participants
We analysed data on all percutaneous coronary intervention procedures for a chronic total occlusion (CTO-PCI) that were undertaken for patients with stable angina in England and Wales between January 1, 2006, and December 31, 2014.
Setting, Data Source, and Study Size
Data on CTO-PCI practice in the United Kingdom were obtained from the BCIS dataset that records data prospectively and publishes this information in the public domain as part of the national transparency agenda. The quality of these data has previously been validated. 12 The data collection process is overseen by the National Institute of Cardiovascular Outcomes Research (http:// www.ucl.ac.uk/nicor/) with high levels of case ascertainment. In 2013, 98.6% of all PCI procedures performed in the National Health Service hospitals in England and Wales (www.bcis.org. uk/) were recorded on the database. The BCIS-National Institute of Cardiovascular Outcomes Research database contains 113 clinical, procedural, and outcomes variables with ≈80 000 new records added each year (https://www.bcis.org.uk/resources/ bcis-ccad-database-resources/datasets-history/). The participants of the database are tracked by the Medical Research Information Services using data from the Office of National Statistics for subsequent mortality using the patients' National Health Service number (a unique identifier for any people registered within the National Health Service in England and Wales). Patients were excluded if the CTO-PCI was undertaken in the setting of an acute coronary syndrome, if information was missing on CTO ES usage, or if postprocedural CTO outcome was incomplete. Approval for the analysis was granted by both National Institute of Cardiovascular Outcomes Research and Health and Quality Improvement Partnership who hold the data.
Study Definitions
A CTO was defined as a complete occlusion with Thrombolysis in Myocardial Infarction (TIMI) flow grade 0 antegrade through the affected segment of >3 months' duration in the opinion of the operator based on clinical features, angiographic features, or previous imaging. The definition of procedural success was as used in a previous BCIS-derived CTO-PCI study, that is, less than a <50% residual stenosis with antegrade TIMI flow grade 3 at the end of the procedure. 13 The BCIS database does not further differentiate patients with a stenosis of <50%, and therefore, other previously used definitions
WHAT IS KNOWN
• Previous chronic total occlusion (CTO) registries have shown higher procedural success rates when adopting specialized CTO tools and techniques.
• Specialized CTO centers and operators can achieve high procedural success rates.
WHAT THE STUDY ADDS
• For the first time, national trends in chronic total occlusion percutaneous coronary intervention success are presented.
• Success rates are examined on a national basis, rather than CTO specialist centers, and reveal that familiarity with CTO techniques, procedural volumes, and experience all improve success rates.
• Use of multiple CTO techniques, however, is associated with more procedural complications and in-hospital bleeding/major adverse cardiovascular events, and therefore operators should be practiced and familiar with managing these when they occur.
of CTO success, such as a <30% cutoff could not be used in this study. ESs to facilitate CTO-PCI were defined as one of the following: dual arterial access, intravascular ultrasound, atherectomy (rotational or laser), penetration catheters (recorded in the BCIS database as Tornus, Asahi Intecc, Santa Ana, CA or Gopher Gold, Vascular Solutions, Minneapolis, MN), microcatheters, or CrossBoss/Stingray balloon. Operator volume was defined as the total individual operator CTO-PCI volume performed in the later 3 study years. Year of procedure was also included in the data collected.
The clinical outcomes examined were access site complication, transfusion, in-hospital major bleeding, periprocedural myocardial infarction (MI), cerebrovascular accident, in-hospital mortality, and 30-day mortality. In-hospital major adverse cardiovascular or cerebrovascular events were defined as a combination of in-hospital death, stroke, or MI. An access site complication was defined as either a false aneurysm, hemorrhage (without hematoma), hemorrhage with delayed discharge, retroperitoneal hematoma, arterial dissection, or any access site complication requiring surgical repair. In-hospital major bleeding was defined as a composite of clinical tamponade after coronary perforation, gastrointestinal bleed, intracerebral bleed, retroperitoneal hematoma, blood or platelet transfusion, or an arterial access site hemorrhage.
Data Analyses
Procedures were categorized into use of no, 1, 2 or ≥3 ESs and patient baseline demographics, procedural details, and complications, and outcomes are presented by ESs category. Procedural success was analysed by procedure year, by number of ESs used, and by procedure year for each number of ESs used. We tested for associations between categorical variable using a χ 2 test, and for continuous variables, we used 1-way ANOVA. Annualized changes in ES usage and success rates were analysed using linear regression. We performed a multivariable analysis of the predictors of procedural success using multivariable logistic regression to investigate the influence of variables that have the potential for being included in the model. Final model selection was done as follows: we first imputed missing data on baseline covariate using multiple imputations with chained equation. We then ran a stepwise forward selection with a logistic regression with P<0.1 as entry criteria. Factors included in the model were creatinine, age, hypertension, peripheral vascular disease, cerebrovascular disease, previous MI, previous coronary artery bypass surgery, previous PCI, diabetes mellitus, target vessel, number of ESs, year of PCI, and operator CTO-PCI volume.
The clinical outcomes were initially calculated as crude rates by ES use. To correct for potential baseline imbalances about the number of ESs used and their association with clinical outcomes, we used a propensity score estimation for multiple treatments using generalized boosting. The model generates estimates of the average treatment effect on the population. The stopping rule for the algorithm used the absolute standardized mean difference. Evaluation of the performance of the algorithm and weights properties were graphically assessed using the twang R package. Weights were then included in the logistic regression using proc survey logistic in SAS. Factors included in the model were age, female sex, previous MI, previous CABG, previous PCI, diabetes mellitus, ejection fraction <30%, smoking history, hypertension, peripheral vascular disease, cerebrovascular disease, and renal failure. To check for the balance, comparisons of the absolute standardized mean differences between the ES categories on the covariates before and after weightings were undertaken (Appendix in the Data Supplement). The P values expressed for comparison between ES use are from tests for trends. All statistical analyses were done using SAS 9.4 and R version 3.4.1.
RESULTS

Temporal Changes in CTO-PCI and ES Use
Of 210 432 stable angina PCI procedures performed in England and Wales between 2006 to 2014, 29 507 were for chronic occlusive disease. Of these, 1457 had missing data for ES use and were excluded leaving 28 050 CTO-PCI procedures in the final analysis ( Figure  I in the Data Supplement). The overall numbers of CTO-PCI peaked in 2008 (n=3402) with a decline in overall numbers and percentage of total PCI in later study years ( Figure 1 , left). Additionally, CTO-PCI as a total of all stable angina declined slightly during the study period ( Figure 1 , right). There were significant increases in annualized use of intravascular ultrasound, atherectomy, penetration catheters, microcatheters, CrossBoss/ Stingray, and dual access during the study period (P<0.001 for all trends; Figure 2 ). The individual components of the ES categories are presented in Figure 3 . There was a steady and significant decline in CTO-PCI cases performed using no ESs with significant increases in 1, 2, or ≥3 ESs being used ( Figure 4 ). However, even in 2014, 32.3% of CTO-PCI cases did not use any ESs and only 8.5% of cases used ≥3.
Baseline Patient Demographics and Procedural Detail by ES Use
Increasing ES use was closely associated with patient comorbidity. A history of hypertension, diabetes mellitus, MI, smoking, peripheral or cerebrovascular disease, and renal disease all increased in a stepwise manner (P<0.001 for all trends) as the number of ESs used increased (Table 1) . Additionally, previous revascularization with either PCI or CABG (P<0.001 for both) was also significantly more likely with increasing ES use. During PCI, the likelihood of femoral arterial access increased progressively with ES use (P<0.001), whereas a trainee first operator decreased significantly with ES use (Table 2) . Left main and right coronary artery PCI was associated with greater ES use (P<0.001), whereas circumflex, left anterior descending artery, and graft PCI were associated with a lower ES use (P<0.001). The number of stents used, stent size, and length of stent increased progressively with ES use.
Immediate Procedural Outcomes for CTO-PCI, Operator Volume, and ES Use
There was a negatively skewed distribution of operator volume of CTO-PCI cases with a significant number of low volume operators, a median total operator volume during the 3 study years (2012-2014) of 10 cases and a mean total operator volume of 18.9 cases. Total operator volume varied from 1 to 222 cases. Higher operator CTO-PCI volumes were associated with improved procedural success (P<0.001 for trend; Figure 5 , left). There was a significant increase in overall CTO-PCI success rates from 55.4% in 2006 to 66.9% in 2014 (P<0.001 for trend; Figure 5 , right). The greater the number of ESs used, the higher the likelihood of procedural success, rising from 56.8% with 0 to 83.8% with ≥3 (P<0.001 for trend; Table 3 procedural resuscitation was required more frequently with increased ES use (0.3% for no ESs versus 0.8% for 2 ESs; P=0.01 for trend).
The factors associated with procedural success are presented in Table I previous PCI, previous MI, and previous CABG were all associated with a lower likelihood of CTO-PCI success (Table 4 ). Figure 7 illustrates the relationship between ES use and procedural success.
In-Hospital and 30-Day Outcomes and ESs Use for CTO-PCI
Increasing crude unadjusted in-hospital adverse outcomes were associated with ES use (Table 5 ). Access site complications were observed to increase in a stepwise fashion from 1.1% with 0 ES use to 2.0% with ≥3 (P<0.001 for trend) as did in-hospital major bleeding (0.6% to 1.8% respectively; P<0.001). There was also a stepwise increase in unadjusted in-hospital mortality (P=0.002 for trend), inhospital major adverse cardiovascular or cerebrovascular events (P=0.001 for trend), and 30-day mortality (P<0.001 for trend). There was no difference in the acute kidney injury rates between the different ES groups (P=0.439 for trend). After adjustment to correct for significant baseline differences between the 4 groups, arterial complications (P<0.001 for trend), in-hospital bleeding (P<0.001 for trend), in-hospital mortality (P=0.040 for trend), and inhospital major adverse cardiovascular events (P=0.018 for trend) were associated with increased ES use. At 30-day mortality was not significantly different between the 4 ES groups (Table 6 ).
DISCUSSION
The current study is the first national PCI database analysis of CTO-PCI to study ESs in contemporary practice, and the salient findings can be summarized as follows: (1) ESs have evolved rapidly but even in the most contemporary study year, almost a third of CTO-PCI cases did not use any; (2) use of ESs was independently associated with procedural success; (3) operator volume was independently associated with procedural success; (4) ESs were associated with increased acute procedural complications, such as perforation and were also associated with increased rates of inhospital adverse events, such as mortality, bleeding, and access site complications; (5) however, at 30 days, use of ESs was not associated with any increase in mortality. The evolution of ESs demonstrated in this study has most likely been driven by emerging data demonstrating superiority of a hybrid approach-using ESs, including antegrade escalation, and dissection reentry techniques over the established antegrade single wire approach. [1] [2] [3] [4] [5] [6] Indeed from almost no use in early study years, use rose exponentially with particularly marked increases in dual access (to facilitate distal vessel imaging and retrograde approaches) and microcatheter use. Concurrent with these temporal changes in strategy, the crude overall success rates for CTO-PCI on a national basis increased significantly from 55% to 67% between 2006 and 2014. In subgroup analysis of ES use, it is interesting to note that procedural success rates increased when no strategies were used implying that improved guidewire technology has contributed to procedural success even in the absence of any other strategies being used.
14 This may also be driven by better case selection as knowledge and experience accumulates. However, the greatest increases in procedural success were associated with ≥3 ESs supporting the hybrid strategy as the way forward in CTO-PCI. These data are particularly impressive given the increasing patient complexity associated with ES use. In multivariable analysis, the greatest ORs of procedural success were associated with 2 and ≥3 ESs with almost 9 in 10 procedures successful in 2014 when ≥3 were used. These data support the utility of ESs in facilitating procedural success, but it is also likely that increased ES use is a marker of operator expertise and operator volume. 15 Indeed, independent of ES use, operator CTO-PCI volume was associated with procedural success. Additionally, later procedure years were also independently associated with improved success rates for CTO-PCI. Taken together, these data support the concept of CTO specialists within PCI centers who can accrue greater procedural volumes and experience and familiarize themselves with all the available ESs to optimize CTO procedural success.
The rapid increase in success rates for ≥3 strategies illustrates a significant learning curve and reiterates the importance of being familiar with the technologies and techniques available in what is undoubtedly complex PCI. The importance of proctoring should also not be underestimated, and many United Kingdom CTO centers run a proctorship program both in their own center and on a visiting basis. Indeed, a UK-based study demonstrated that proctoring resulted in an increase in overall procedural success for CTO-PCI, a greater increase in the more complex CTO-PCI being undertaken and an increase in total CTO-PCI activity. 16 One interesting finding of the current study is lack of growth in crude PCI numbers. The lack of growth in CTO-PCI we think represents a maturation of CTO-PCI practice in the United Kingdom. The data in the current study demonstrates that the poke and hope approach, that is, with no ES use, has declined significantly in frequency. This suggests that operators are now more cognizant of the skills and tools needed to achieve satisfactory CTO-PCI outcomes and are less inclined to take on a CTO without the appropriate skill set. Most large volume UK centers now have a proper CTO multidisciplinary team meeting and a least 1 dedicated CTO operator. Therefore, we think that the lack of growth in CTO numbers represents evidencebased practice, proper patient selection, and likely full informed patient consent as to the likely benefits and risk of the procedure.
The finding of small increases in-hospital mortality associated with complex CTO-PCI is important and most likely relates to increases in coronary perforation, transfusion, access site complications, and major bleeding. An understanding of the potential risks of these complex procedures is particularly relevant to case selection and a fully informed consenting process. Consistent with previous data, coronary perforation was associated with ES use. 10, [17] [18] [19] [20] [21] It is perhaps not surprising in view of techniques, such as subintimal tracking and retrograde techniques that such a complication is more frequent and highlights the importance of CTO operators being well trained in treating predictable complications during a complex procedure. The avoidance of surgical repair is clearly highly desirable, and the utilization of covered stents, as well as a wider appreciation of techniques, such as ping-pong guides, and embolization coils, distal fat, or thrombus embolization to treat wire tip perforations, have facilitated such low rates of mortality after perforation. [22] [23] [24] Another contributory factor to the excess in-hospital major adverse cardiovascular events observed with increasing ES use may be the high rates of femoral artery use and especially dual arterial access. In a previous study of access site choice using data derived from the BCIS database, we demonstrated that although femoral artery utilization fell from 84.6% in 2006 to 57.9% in 2013, major bleeding (0.8% versus 0.2%; P<0.001), transfusion (0.4% versus 0%; P<0.001), and 30-day death (0.6% versus 0.1%; P=0.002) were all more frequent in patients undergoing CTO-PCI using femoral access compared with radial access. 25 Recent data from the RECHARGE registry (Registry of Crossboss and Hybrid) demonstrate the feasibility of avoiding the femoral artery for CTO-PCI with 25% of cases undertaken radially or biradially with technical success being comparable between the 2 access sites. 26 Other data suggests lower success rates associated with radial access for complex CTO-PCI and, therefore, there remains a lack of consensus as to the role of routine radial access in this setting. 27 Despite this, as experience and techniques further evolve, and ES equipment becomes increasingly slender, increased radial artery use may in part ameliorate the adverse inhospital outcomes of patients treated using several ESs.
At 30 days, however, it is reassuring to observe that the trend for increased in-hospital mortality associated with the use of ESs was no longer evident with equivalent survival across all 4 groups. Additionally, it is also relevant to consider a previous analysis of CTO-PCI derived from the BCIS database, which showed that at 12-months, procedural success was associated with improved survival. 13 A strength of this analysis is that it is the first national scale examination of ES use and outcomes for CTO-PCI. As such, there are sufficient numbers of cases to allow not only temporal trend analysis of overall outcomes Clinical outcomes adjusted for baseline differences using a propensity score estimation for multiple treatments. MACCE indicates major adverse cardiovascular or cerebrovascular events.
but also a trend analysis for the various subgroups of ES use. Additionally, the large numbers of procedures allow analysis of relatively infrequent events such as coronary perforation and in-hospital death after stable angina PCI. In considering the limitations, first, as with any database, the robustness of the conclusions is directly related to the quality of data entered. Although there are high levels of case ascertainment and field completion within the database, the accuracy of field completion for individual centers cannot be validated. Second, we can only provide on fields continue within the BCIS dataset. As procedure time, fluoroscopy time, and radiation dose are not recorded, we cannot provide any data on these procedural outcomes. Although these data have previously been derived from CTO databases, such as RECHARGE, 4 the lack of information on these relevant end points is a limitation of the present study. Additionally, the BCIS does not record contrast volume although it is reassured to observe a similar frequencies of acute kidney injury between the different ES groups. Third, the BCIS database does not gather data on specific CTO techniques such as knuckling, retrograde or antegrade dissection reentry, wire escalation, or use of septal or epicardial collaterals. Therefore, although we have used the ESs as defined in the current study as surrogates for these cornerstone CTO strategies, temporal changes in their use will undoubtedly have influenced procedural success and we are unable to add their use to the modeling of procedural success. However, this limitation does not affect the primary finding of the study, that is, that for the first time on a national basis, we have shown temporal changes in CTO success rates, correlating these improvements with general changes in ES use. The BCIS database did not capture detailed CTO anatomy, such as proximal cap shape or ambiguity, presence of side-branches, length of the occlusion, or the degree of vessel calcification or tortuosity. Although without the anatomic data we cannot rule out the possibility that greater ES use was associated with less complex CTOs, this seems unlikely given that the patients and procedures were more complex as ES use increased. Conversely, it seems more plausible that if granular anatomic data were available and adjusted for in the procedural success modeling, that even greater ORs of procedural success might be observed with greater ES use. Finally, the frequencies of certain clinical outcomes were low in part due to the exclusion of acute coronary syndrome patients. Therefore the study is unable to robustly study some clinical events such as periprocedural stroke and their occurrence with variable ES use.
CONCLUSIONS
The use of ESs during CTO-PCI has increased rapidly in recent years, and their use is associated with significant improvement in CTO success. Although increases in complications, such as coronary perforation, access site bleeding, and in-hospital mortality were associated with ES use, there were no differences in adjusted mortality at 30 days.
